...
首页> 外文期刊>Europace: European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology >Left ventricular function improvement after prophylactic implantable cardioverter-defibrillator implantation in patients with non-ischaemic dilated cardiomyopathy
【24h】

Left ventricular function improvement after prophylactic implantable cardioverter-defibrillator implantation in patients with non-ischaemic dilated cardiomyopathy

机译:非缺血性扩张型心肌病患者预防性植入式心脏复律除颤器植入后左心室功能改善

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: To assess the incidence and prognostic significance of left ventricular (LV) function improvement in patients with non-ischaemic dilated cardiomyopathy (DCM) and prophylactic implantable cardioverter-defibrillator (ICD). Methods and results: A total of 123 patients with DCM and echocardiographic follow-up assessments within 1 year after prophylactic ICD implant were retrospectively studied at our institution. All patients had New York Heart Association class II or III symptoms in the presence of a LV ejection fraction of 23 + 6% (range: 9-35%) despite optimized medical therapy for at least 3 months prior to ICD implant. Left ventricular function improvement was defined as an increase of LV ejection fraction of more than 5% to more than 35% combined with a decrease LV end-diastolic diameter of at least 5 mm. Left ventricular function improvement after prophylactic ICD implant was found in 30 of 123 patients (24%). Multivariate logistic regression revealed recent onset DCM with symptoms <9 months as the only significant predictor of LV function improvement [odds ratio: 6.89; 95% confidence interval (Cl): 2.43-21.99, P = 0.0002]. During 74 months mean follow-up, total mortality was higher in patients without vs. with LV function improvement [hazard ratio (HR): 3.75; 95% Cl: 1.14-12.31, P = 0.0034], while the incidence of appropriate ICD therapies was similar in both groups in the early phase after prophylactic ICD implant (HR: 1.15; 95% Cl: 0.57-2.33, P= 0.70). The incidence of appropriate ICD therapies decreased to ~1% per year after LV function improvement had occurred.Conclusion: Recently diagnosed DCM predicts LV function improvement after prophylactic ICD implant. Overall survival was sig-nificantly better in patients with vs. without LV function improvement, while appropriate ICD therapy rates were similar in both groups in the early phase after prophylactic ICD implantation before LV function improvement occurred.
机译:目的:评估非缺血性扩张型心肌病(DCM)和预防性植入式心脏复律除颤器(ICD)患者左心室(LV)功能改善的发生率和预后意义。方法和结果:回顾性研究了我院123例接受预防性ICD植入后1年内DCM和超声心动图随访评估的患者。尽管在植入ICD之前至少进行了3个月的优化药物治疗,但所有患者均具有23 + 6%左室射血分数(9-35%)的纽约心脏协会II级或III级症状。左心室功能改善定义为左心室射血分数增加超过5%至35%以上,同时左心室舒张末期直径减少至少5 mm。 123例患者中有30例(24%)发现预防性ICD植入后左心室功能得到改善。多因素logistic回归分析显示,最近发作的DCM症状<9个月是左室功能改善的唯一重要预测指标[几率:6.89; 95%置信区间(Cl):2.43-21.99,P = 0.0002]。在平均随访的74个月中,没有左室功能改善的患者的总死亡率较高[危险比(HR):3.75; 95%Cl:1.14-12.31,P = 0.0034],而预防性ICD植入后两组早期适当ICD治疗的发生率相似(HR:1.15; 95%Cl:0.57-2.33,P = 0.70) 。左室功能改善后,适当的ICD治疗的发生率每年降低至〜1%。结论:最近诊断为DCM的患者可预测预防性ICD植入后左室功能的改善。有和没有左室功能改善的患者的总生存期明显好得多,而预防性ICD植入后早期,在左室功能改善发生之前,两组的适当ICD治疗率相似。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号